previous compound ID: 1982 next compound
InChIKey: ROBVIMPUHSLWNV-UHFFFAOYSA-N
SMILES: CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "R Robert" "J Goepp" "JW Hanrahan" "GW Carlile" "E Matthes" "B Kus" "J Liao" "D Rotin" "DY Thomas"

chemical graph of compound 1982





CID is 2145
synonyms found at PubChem are:
aminoglutethimide, 125-84-8, dl-Aminoglutethimide, Cytadren, Orimeten, p-Aminoglutethimide, Elipten, 3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione, Aminoglutetimida, 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione, Aminoglutethimidum, 2-(p-Aminophenyl)-2-ethylglutarimide, 2,6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl-, Ba-16038, 3-Ethyl-3-(p-aminophenyl)-2,6-dioxopiperidine, (+/-)-p-AMINOGLUTETHIMIDE, Aminoglutethimidum [INN-Latin], Aminoglutetimida [INN-Spanish], Aminoglutetimide, Glutethimide, para-amino, Ba 16038, Cytadren (TN), Aminoglutethimide [INN:BAN], C 16038-BA, AG-1, CCRIS 7562, Glutarimide, 2-(p-aminophenyl)-2-ethyl-, aminoglutethimide (AG), 3-(4-Aminophenyl)-3-ethyl-2,6-piperidindion, EINECS 204-756-4, CHEMBL488, BRN 0210656, Aminoglutethimide (USP/INN), CHEBI:2654, alpha-(p-Aminophenyl)-alpha-ethylglutarimide, 3-(p-Aminophenyl)-3-ethylpiperidine-2,6-dione, ROBVIMPUHSLWNV-UHFFFAOYSA-N, 3-(4-aminophenyl)-3-ethyl-piperidine-2,6-dione, NSC-330915, DSSTox_CID_2589, A 9657, DSSTox_RID_76647, .alpha.-(p-Aminophenyl)-.alpha.-ethylglutarimide, DSSTox_GSID_22589, (RS)-2-(4-Amino-phenyl)-2-ethyl-glutarimide;(RS)-3-(4-Amino-phenyl)-3-ethyl-2,6-dioxo-piperidine, SMR000326785, SR-01000075596, Aminoglutethimid, HSDB 7494, Aminoglutethimide [USP:INN:BAN], NCGC00016379-01, CAS-125-84-8, Prestwick_243, Spectrum_000040, (y)-p-Aminoglutethimide, AC1Q2SPJ, Aminoglutethimide AG, 4, (?)-p-Aminoglutethimide, Prestwick0_000244, Prestwick1_000244, Prestwick2_000244, Prestwick3_000244, Spectrum2_000093, Spectrum3_000296, Spectrum4_000144, Spectrum5_000802, D0M6DO, AC1L1D0R, SCHEMBL4306, Aminoglutethimide (Cytadren), Lopac0_000124, BSPBio_000028, BSPBio_001832, KBioGR_000588, KBioSS_000400, (A+/-)-p-Aminoglutethimide, MLS000859924, MLS001213216, DivK1c_000884, SPECTRUM1500115, SPBio_000046, SPBio_002247, BDBM9460, BPBio1_000032, GTPL7054, DTXSID8022589, CTK6D0224, HMS502M06, KBio1_000884, KBio2_000400, KBio2_002968, KBio2_005536, KBio3_001332, NINDS_000884, HMS1568B10, HMS1920C09, HMS2090I05, HMS2091I09, HMS2095B10, HMS2231M19, HMS3259H10, HMS3260I10, HMS3372M07, HMS3655O17, HMS3712B10, Pharmakon1600-01500115, Novartis Brand of Aminoglutethimide, BCP28501, EBD40055, HY-B0237, 2, 3-(4-aminophenyl)-3-ethyl-, Tox21_110406, Tox21_303497, Tox21_500124, BBL010961, CCG-38911, MFCD00010122, NSC330915, NSC755868, SBB000711, STK802074, AKOS004120070, AKOS022060651, Ciba Vision Brand of Aminoglutethimide, Tox21_110406_1, AT-2947, CS-2205, DB00357, LP00124, MCULE-9118268281, NC00714, NSC-755868, IDI1_000884, SMP1_000017, NCGC00015110-02, NCGC00015110-03, NCGC00015110-04, NCGC00015110-05, NCGC00015110-06, NCGC00015110-07, NCGC00015110-09, NCGC00015110-12, NCGC00093615-01, NCGC00093615-02, NCGC00093615-03, NCGC00093615-04, NCGC00093615-05, NCGC00257263-01, NCGC00260809-01, AC-12456, AN-43553, AS-13282, CPD000326785, H801, LS-72014, NCI60_002900, SAM002589964, SC-12125, SBI-0050112.P004, AB0013271, AB2000209, DB-021640, (inverted question mark)-p-Aminoglutethimide, AB00051935, EU-0100124, FT-0622284, S1672, ( inverted question mark)-p-Aminoglutethimide, EN300-53368, VU0243029-3, C07617, D00574, K-1913, AB00051935-09, AB00051935-11, AB00051935_12, AB00051935_13, 125A848, A805433, 3-(4-aminophenyl)-3-ethylazaperhydroine-2,6-dione, SR-01000075596-1, SR-01000075596-4, SR-01000075596-6, W-108399, (+-)-3-(p-Aminophenyl)-3-ethyl-2,6-piperidinedione, BRD-A25234499-001-05-0, BRD-A25234499-001-09-2, Z1259341083, Aminoglutethimide, European Pharmacopoeia (EP) Reference Standard, Aminoglutethimide, United States Pharmacopeia (USP) Reference Standard